Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA panel votes to support NPS Pharma bowel drug
Yahoo/AP
Wednesday, October 17, 2012 - 11:55am
tags:
NPS Pharmaceuticals, FDA, short bowel syndrome, Gattex, advisory panels
FDA Approves Neuralstem To Treat Second Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder
Yahoo/AP
Wednesday, October 17, 2012 - 11:54am
tags:
FDA, Neuralstem, NSI-189, major depressive disorder
Nabi says nicotine vaccine fails again
Yahoo/AP
Wednesday, October 17, 2012 - 11:53am
tags:
Nabi, smoking cessation, vaccines, NicVax, Chantix
3 Reasons Why Eisai Should Purchase Arena Pharmaceuticals
Motley Fool
Wednesday, October 17, 2012 - 11:51am
tags:
Arena Pharmaceuticals, Eisai, Belviq
3 Biotechs With Good FDA News
Motley Fool
Wednesday, October 17, 2012 - 11:49am
tags:
FDA, Arqule, Threshold Pharmaceuticals, Amarin
Ironwood Pharma posts 3Q profit on drug approval
Yahoo/AP
Wednesday, October 17, 2012 - 11:29am
tags:
Ironwood Pharmaceuticals, earnings, Linzess
Multiple Catalysts Ahead For Depomed
Seeking Alpha
Wednesday, October 17, 2012 - 11:28am
tags:
Depomed, BioSante, Serada
Earnings Preview: Cubist Pharma
Yahoo/Zacks
Wednesday, October 17, 2012 - 11:26am
tags:
Cubist Pharmaceuticals, earnings
Judge Denies Pfizer Request for Delay in Chantix Trial
NASDAQ.com
Wednesday, October 17, 2012 - 11:21am
tags:
Pfizer, Chantix
Eisai’s Epilepsy Drug Helps Obese Patients Reduce Weight
Bloomberg
Wednesday, October 17, 2012 - 11:20am
tags:
Eisai, epilepsy, obesity, Zonegran
Digesting Johnson & Johnson's Q3 Earnings
Seeking Alpha
Wednesday, October 17, 2012 - 11:19am
tags:
JNJ, earnings
Sarepta Presents 48-Week Data For Duchenne's Drug At World Muscle Society Congress
Seeking Alpha
Wednesday, October 17, 2012 - 11:19am
tags:
Sarepta, Duchenne Muscular Dystrophy, eteplirsen
Abbott 3rd-qtr profit tops view, but sales disappoint
Reuters
Wednesday, October 17, 2012 - 11:04am
tags:
earnings, Abbott Labs
Nobel Prize Validates Recent Stem Cell Headlines
Seeking Alpha
Tuesday, October 16, 2012 - 11:57am
tags:
stem cells, Neuralstem, NeoStem, Baxter International, Osiris, StemCells
Swiss drugmaker Roche posts strong rise in sales thanks to cancer-fighting products
Yahoo/AP
Tuesday, October 16, 2012 - 11:53am
tags:
Roche
NPS shares halted as FDA panel reviews bowel drug
Yahoo/AP
Tuesday, October 16, 2012 - 11:52am
tags:
NPS Pharmaceuticals, FDA, advisory panels, Gattex, short bowel syndrome
Forest Labs profit plunges as generics eat into Lexapro sales
Bloomberg
Tuesday, October 16, 2012 - 11:39am
tags:
Forest Labs, earnings
Isis Falls on Concerns Over Abnormal Growths With Kynamro
Bloomberg
Tuesday, October 16, 2012 - 11:39am
tags:
Isis Pharmaceuticals, Kynamro, mipomersen, Homozygous Familial Hypercholesterolemia
FTC Places Conditions on Watson Pharmaceutical's Proposed Acquisition of Actavis
PharmPro
Tuesday, October 16, 2012 - 11:29am
tags:
FTC, Watson Pharmaceuticals, M&A, Actavis
Novartis Drug Diovan Retains 69% of Prescriptions in U.S.
Bloomberg
Tuesday, October 16, 2012 - 10:51am
tags:
Novarits, Diovan, generics, Sandoz

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.